Status:
COMPLETED
Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)
Lead Sponsor:
Starpharma Pty Ltd
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the efficacy of SPL7013 Gel in the treatment of bacterial vaginosis.
Eligibility Criteria
Inclusion
- Women aged 18-45 years with a diagnosis of BV according to Amsel's criteria and a Nugent score of ≥4
- Otherwise healthy
Exclusion
- No active STIs
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01201057
Start Date
August 1 2010
End Date
May 1 2011
Last Update
June 6 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Precision Trials
Phoenix, Arizona, United States, 85032
2
Downtown Women's Health Care
Denver, Colorado, United States, 80218
3
Clinical Research Center of Nevada
Las Vegas, Nevada, United States, 89104
4
Bexar Clinical Trials, LLC
Irving, Texas, United States, 75061